Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) is among the best fast money stocks to buy now. Analysts at JMP Securities have reaffirmed their ‘Market Outperform’ rating on Crinetics Pharmaceuticals, ...

PCOS Awareness Month highlights common questions and misconceptions about Polycystic Ovary Syndrome, offering clarity and ...

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report third quarter 2025 financial results on ...

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on October 10, 2025, the Compensation Committee of the ...

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on October 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified ...

Detailed price information for Crinetics Pharmaceuticals Inc (CRNX-Q) from The Globe and Mail including charting and trades.

Patients with primary adrenal insufficiency had a higher risk for all-cause mortality than the general population or control individuals without the condition, with cardiovascular disease being a ...

More than half of adults who underwent a unilateral adrenalectomy to treat mild autonomous cortisol secretion developed adrenal insufficiency, according to data published in The Journal of Clinical ...

This article was reviewed by Felix Gussone, MD. What Is Testosterone? As the primary male hormone, or androgen, testosterone ...

The addition of sotatercept, an activin-signaling inhibitor, to background therapy results in a lower risk for clinical worsening among adults with pulmonary arterial hypertension (PAH) who were ...

Higher biochemical severity scores and younger age were associated with higher risk for adrenal insufficiency following unilateral adrenalectomy.

University of Virginia provides funding as a member of The Conversation US. Autumn brings a chill in the air – and the start of another season of respiratory illnesses, which can be especially hard ...